OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Fate of PEGylated antibody fragments following delivery to the lungs: Influence of delivery site, PEG size and lung inflammation
Harshad P. Patil, Danielle Freches, Linda Karmani, et al.
Journal of Controlled Release (2017) Vol. 272, pp. 62-71
Closed Access | Times Cited: 44
Harshad P. Patil, Danielle Freches, Linda Karmani, et al.
Journal of Controlled Release (2017) Vol. 272, pp. 62-71
Closed Access | Times Cited: 44
Showing 26-50 of 44 citing articles:
Computational fluid dynamics modeling of aerosol particle transport through lung airway mucosa
Blake A. Bartlett, Yu Feng, Catherine A. Fromen, et al.
Computers & Chemical Engineering (2023) Vol. 179, pp. 108458-108458
Open Access | Times Cited: 5
Blake A. Bartlett, Yu Feng, Catherine A. Fromen, et al.
Computers & Chemical Engineering (2023) Vol. 179, pp. 108458-108458
Open Access | Times Cited: 5
Nanomedicine to advance the treatment of bacteria-induced acute lung injury
Ruonan Su, Yu Zhang, Jiabin Zhang, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 44, pp. 9100-9115
Closed Access | Times Cited: 12
Ruonan Su, Yu Zhang, Jiabin Zhang, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 44, pp. 9100-9115
Closed Access | Times Cited: 12
Advances in Pulmonary Protein Delivery Systems
Yuanyuan Zhao, Shuai Liu, Xueguang Lu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 1
Yuanyuan Zhao, Shuai Liu, Xueguang Lu
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 5
Open Access | Times Cited: 1
Integration of mucus and its impact within in vitro setups for inhaled drugs and formulations: Identifying the limits of simple vs. complex methodologies when studying drug dissolution and permeability
Snezana Radivojev, Lukas Kargl, Joana T. Pinto, et al.
International Journal of Pharmaceutics (2024) Vol. 661, pp. 124455-124455
Closed Access | Times Cited: 1
Snezana Radivojev, Lukas Kargl, Joana T. Pinto, et al.
International Journal of Pharmaceutics (2024) Vol. 661, pp. 124455-124455
Closed Access | Times Cited: 1
Vaginal delivery of mucus-penetrating organic nanoparticles for photothermal therapy against cervical intraepithelial neoplasia in mice
Xue Wang, Li Fu, Wenhai Lin, et al.
Journal of Materials Chemistry B (2019) Vol. 7, Iss. 29, pp. 4528-4537
Closed Access | Times Cited: 11
Xue Wang, Li Fu, Wenhai Lin, et al.
Journal of Materials Chemistry B (2019) Vol. 7, Iss. 29, pp. 4528-4537
Closed Access | Times Cited: 11
Significant Unresolved Questions and Opportunities for Bioengineering in Understanding and Treating COVID-19 Disease Progression
Jasmine Shirazi, Michael J. Donzanti, Katherine M. Nelson, et al.
Cellular and Molecular Bioengineering (2020) Vol. 13, Iss. 4, pp. 259-284
Open Access | Times Cited: 10
Jasmine Shirazi, Michael J. Donzanti, Katherine M. Nelson, et al.
Cellular and Molecular Bioengineering (2020) Vol. 13, Iss. 4, pp. 259-284
Open Access | Times Cited: 10
PEGylation of Recombinant Human Deoxyribonuclease I Provides a Long‐Acting Version of the Mucolytic for Patients with Cystic Fibrosis
Marie‐Julie Guichard, Tobias Wilms, Sohaib Mahri, et al.
Advanced Therapeutics (2020) Vol. 4, Iss. 2
Closed Access | Times Cited: 10
Marie‐Julie Guichard, Tobias Wilms, Sohaib Mahri, et al.
Advanced Therapeutics (2020) Vol. 4, Iss. 2
Closed Access | Times Cited: 10
PEGylation of recombinant human deoxyribonuclease I decreases its transport across lung epithelial cells and uptake by macrophages
Sohaib Mahri, Eléonore Hardy, Tobias Wilms, et al.
International Journal of Pharmaceutics (2020) Vol. 593, pp. 120107-120107
Open Access | Times Cited: 10
Sohaib Mahri, Eléonore Hardy, Tobias Wilms, et al.
International Journal of Pharmaceutics (2020) Vol. 593, pp. 120107-120107
Open Access | Times Cited: 10
Nanotechnology for pulmonary and nasal drug delivery
Amir Hossein Bahmanpour, Maryam Ghaffari, Sajjad Ashraf, et al.
Elsevier eBooks (2020), pp. 561-579
Closed Access | Times Cited: 9
Amir Hossein Bahmanpour, Maryam Ghaffari, Sajjad Ashraf, et al.
Elsevier eBooks (2020), pp. 561-579
Closed Access | Times Cited: 9
The role of antibody delivery formation in cancer therapy
Tongtong Qi, Yanbin Shi, Yi Huang, et al.
Journal of drug targeting (2020) Vol. 28, Iss. 6, pp. 574-584
Closed Access | Times Cited: 7
Tongtong Qi, Yanbin Shi, Yi Huang, et al.
Journal of drug targeting (2020) Vol. 28, Iss. 6, pp. 574-584
Closed Access | Times Cited: 7
Strategies for overcoming the biological barriers associated with the administration of inhaled monoclonal antibodies for lung diseases
Maria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1085-1095
Closed Access | Times Cited: 2
Maria Gabriella Matera, Luigino Calzetta, Barbara Rinaldi, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 8, pp. 1085-1095
Closed Access | Times Cited: 2
Preclinical evaluation of topically-administered PEGylated Fab’ lung toxicity
Danielle Freches, Natacha Rocks, Harshad P. Patil, et al.
International Journal of Pharmaceutics X (2019) Vol. 1, pp. 100019-100019
Open Access | Times Cited: 5
Danielle Freches, Natacha Rocks, Harshad P. Patil, et al.
International Journal of Pharmaceutics X (2019) Vol. 1, pp. 100019-100019
Open Access | Times Cited: 5
Application of Nanobiomedicine in Acute Lung Injury
Doudou Lei, B Wang, Mingjing Yin, et al.
Journal of Biomaterials and Tissue Engineering (2024) Vol. 14, Iss. 3, pp. 115-129
Closed Access
Doudou Lei, B Wang, Mingjing Yin, et al.
Journal of Biomaterials and Tissue Engineering (2024) Vol. 14, Iss. 3, pp. 115-129
Closed Access
A breath of fresh air: inhaled antibodies to combat respiratory infectious diseases - a clinical trial overview
Noémie Alphonse, Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2024)
Closed Access
Noémie Alphonse, Thomas Sécher, Nathalie Heuzé-Vourc’h
Expert Opinion on Drug Delivery (2024)
Closed Access
The role of airway mucus and diseased pulmonary epithelium on the absorption of inhaled antibodies
Adriana Martinez Ledo, Thomas Dimke, William R. Tschantz, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123519-123519
Closed Access | Times Cited: 1
Adriana Martinez Ledo, Thomas Dimke, William R. Tschantz, et al.
International Journal of Pharmaceutics (2023) Vol. 647, pp. 123519-123519
Closed Access | Times Cited: 1
Pulmonary Delivery of Antibody for the Treatment of Respiratory Diseases
Thomas Sécher, Nathalie Heuzé-Vourc’h
AAPS introductions in the pharmaceutical sciences (2023), pp. 21-51
Closed Access | Times Cited: 1
Thomas Sécher, Nathalie Heuzé-Vourc’h
AAPS introductions in the pharmaceutical sciences (2023), pp. 21-51
Closed Access | Times Cited: 1
Synthetic mucus barrier arrays as a nanoparticle formulation screening platform
Harry Zou, Allison Boboltz, Yahya Cheema, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Harry Zou, Allison Boboltz, Yahya Cheema, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Size- and site-dependent distribution of therapeutic proteins into thoracic lymph
Kinam Park
Journal of Controlled Release (2018) Vol. 272, pp. 182-182
Closed Access
Kinam Park
Journal of Controlled Release (2018) Vol. 272, pp. 182-182
Closed Access
Computational Fluid Dynamics Modeling of Aerosol Particle Transport through Lung Airway Mucosa
Blake A. Bartlett, Yu Feng, Catherine A. Fromen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
Blake A. Bartlett, Yu Feng, Catherine A. Fromen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access
